Breaking News Instant updates and real-time market news.

TSLA

Tesla

$292.16

4.46 (1.55%)

09:14
04/04/19
04/04
09:14
04/04/19
09:14

Tesla worsening mix biggest negative surprise from Q1, says Morgan Stanley

Morgan Stanley analyst Adam Jonas said he views the deteriorating sale mix of Model S and X vehicles compared to Model 3s was the biggest negative surprise in Tesla's Q1 delivery and production report given the high revenue and margin contribution of those two models. Many expected Tesla to disclose its quarter-end cash figure to try to calm the market, but the company only said it has "sufficient cash on hand," noted Jonas, which he said leaves bears to continue to question the firm's financial strength and liquidity. He maintains an Equal Weight rating on Tesla shares with a $260 price target.

  • 22

    Apr

TSLA Tesla
$292.16

4.46 (1.55%)

04/04/19
WEDB
04/04/19
NO CHANGE
Target $365
WEDB
Outperform
Tesla price target lowered to $365 from $390 at Wedbush
Wedbush analyst Daniel Ives lowered his price target for Tesla to $365 from $390 to reflect lower deliveries and a higher chance of capital raise now on the horizon. The analyst notes that Tesla has reported its Q1 production and delivery numbers as well as the number of vehicles currently in transit to customers. Ives notes that the Street was expecting an apocalyptic quarter and Model 3 deliveries were slightly better than feared by many with 50k Model 3 vehicles the "line in the sand." Nonetheless, the overall number was "clearly rocky" and represents an "air pocket" quarter, he contends. The analyst reiterates an Outperform rating on the shares.
04/04/19
BARD
04/04/19
NO CHANGE
Target $465
BARD
Outperform
Tesla estimates lowered on lower deliveries, margins at Baird
Baird analyst Ben Kallo maintained an Outperform rating and $465 price target on Tesla after Model 3 deliveries came in line with expectations, though Model S and X deliveries both his and consensus estimates. Kallo says a high number of cars in transit at the end of the quarter could impact cash flow, though Tesla indicated it had "sufficient" cash flow. Kallo tells investors in a research note that he is lowering estimates to reflect lower-than-expected deliveries and margins, and now sees Q1 revenue of $4.8B, gross margin of 17.3% and adjusted EPS of (69c), with 2019 revenue of $25.4B, gross margin of 20.1% and adjusted EPS of $3.67.
04/04/19
COWN
04/04/19
NO CHANGE
Target $170
COWN
Underperform
Tesla growth narrative 'looks very suspect' after 'ugly' Q1 report, says Cowen
Cowen analyst Jeffrey Osborne said Tesla's "very weak" Q1 production and delivery results "should make bulls nervous" as he contends that the company's growth narrative "looks very suspect" following the report that deliveries were down 31% and production was cut 11% compared to Q4. Tesla management reiterated "the lowest of its several guidance versions," but Osborne believes that lower range is still very aggressive given low demand for the Model S/X and the company's likely need to manage the Model 3 mix to stay profitable. Osborne keeps an Underperform rating on Tesla shares and lowered his price target on the stock to $170 from $180.
04/04/19
ROTH
04/04/19
NO CHANGE
Target $270
ROTH
Neutral
Roth Capital sees 'busy day' ahead for Tesla investors
Roth Capital analyst Craig Irwin believes Thursday will be a "busy day" for Tesla investors with Elon Musk's court date in front of Judge Nathan, "terrible" deliveries numbers, and mounting questions about cash burn and capital market access. The analyst sees the CEO's antics challenging the SEC as "reckless," and could see similar behavior in court. Cash will be impacted by the weak quarter, so questions on capital market access are important, he added. Irwin reiterates a Neutral rating and s $270 price target on the shares.

TODAY'S FREE FLY STORIES

WEC

WEC Energy

$78.05

1.09 (1.42%)

14:21
04/25/19
04/25
14:21
04/25/19
14:21
Earnings
WEC Energy sees Q2 EPS 70c-72c, consensus 74c »

Says guidance assumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 02

    May

  • 21

    May

MDP

Meredith

$58.39

0.04 (0.07%)

14:19
04/25/19
04/25
14:19
04/25/19
14:19
Periodicals
Breaking Periodicals news story on Meredith »

Authentic Brands in talks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 09

    May

  • 13

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
04/25/19
04/25
14:17
04/25/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNSL

Consolidated Communications

$6.09

-2.805 (-31.55%)

14:16
04/25/19
04/25
14:16
04/25/19
14:16
Downgrade
Consolidated Communications rating change  »

Consolidated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 29

    Apr

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
04/25/19
04/25
14:16
04/25/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEC

WEC Energy

$77.97

1.01 (1.31%)

14:12
04/25/19
04/25
14:12
04/25/19
14:12
Earnings
WEC Energy sees FY19 EPS at high end of $3.48-$3.52 range, consensus $3.51 »

Says on track to add…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 02

    May

  • 21

    May

F

Ford

$9.41

-0.17 (-1.77%)

, GM

General Motors

$39.12

-0.61 (-1.54%)

14:10
04/25/19
04/25
14:10
04/25/19
14:10
Earnings
Fly Intel: What to watch in auto sector earnings reports »

Ford (F) is scheduled to…

F

Ford

$9.41

-0.17 (-1.77%)

GM

General Motors

$39.12

-0.61 (-1.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 30

    Apr

  • 01

    May

  • 03

    May

  • 09

    May

  • 05

    Jun

  • 24

    Jul

  • 23

    Oct

CPRI

Capri Holdings

$44.85

-1.26 (-2.73%)

14:05
04/25/19
04/25
14:05
04/25/19
14:05
Options
Capri Holdings call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:00
04/25/19
04/25
14:00
04/25/19
14:00
General news
Treasury Action: the market has eroded slightly »

Treasury Action: the…

CLB

Core Laboratories

$66.31

-6.595 (-9.05%)

13:51
04/25/19
04/25
13:51
04/25/19
13:51
Recommendations
Core Laboratories analyst commentary at Stifel »

Core Laboratories…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 01

    May

AVP

Avon Products

$3.13

0.175 (5.92%)

13:49
04/25/19
04/25
13:49
04/25/19
13:49
Periodicals
Natura said to be in advanced talks to acquire Avon, Valor Economico says »

Natura is in advanced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 16

    May

DLPH

Delphi Technologies

$22.60

-2 (-8.13%)

13:45
04/25/19
04/25
13:45
04/25/19
13:45
Options
Delphi call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

ADTN

Adtran

$17.39

-0.38 (-2.14%)

13:40
04/25/19
04/25
13:40
04/25/19
13:40
Earnings
Adtran VP Roger Shannon sold over $100K in company shares »

Adtran VP Roger Shannon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 08

    May

AVYA

Avaya

$20.22

0.895 (4.63%)

13:34
04/25/19
04/25
13:34
04/25/19
13:34
Periodicals
Mitel offering to combine with Avaya in stock deal worth over $2B, WSJ says »

Avaya is in talks to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

TECK.B

Teck Corp.

$0.00

(0.00%)

13:34
04/25/19
04/25
13:34
04/25/19
13:34
Conference/Events
Teck Corp. management to meet with B.Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

CWT

California Water Service

$49.43

-0.57 (-1.14%)

13:32
04/25/19
04/25
13:32
04/25/19
13:32
Upgrade
California Water Service rating change  »

California Water Service…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

BHC

Bausch Health

$23.18

0.16 (0.70%)

13:30
04/25/19
04/25
13:30
04/25/19
13:30
Hot Stocks
Breaking Hot Stocks news story on Bausch Health »

Bausch Health trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 06

    May

  • 06

    May

AVYA

Avaya

$20.20

0.875 (4.53%)

13:28
04/25/19
04/25
13:28
04/25/19
13:28
Periodicals
Mitel offers to combine with Avaya in stock deal, WSJ says »

Mitel's bid values…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

CLVS

Clovis

$19.43

-0.4 (-2.02%)

13:25
04/25/19
04/25
13:25
04/25/19
13:25
Options
Clovis call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 31

    May

AGN

Allergan

$140.66

0.98 (0.70%)

, TEVA

Teva

$15.07

0.065 (0.43%)

13:25
04/25/19
04/25
13:25
04/25/19
13:25
Conference/Events
Piper Jaffray specialty pharma analysts to hold analyst/industry conference call »

Specialty Pharmaceuticals…

AGN

Allergan

$140.66

0.98 (0.70%)

TEVA

Teva

$15.07

0.065 (0.43%)

ALDR

Alder Biopharmaceuticals

$13.95

0.29 (2.12%)

AMGN

Amgen

$179.82

1.56 (0.88%)

BHVN

Biohaven Pharmaceutical

$62.30

-0.855 (-1.35%)

LLY

Eli Lilly

$117.99

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 28

    Apr

  • 30

    Apr

  • 30

    Apr

  • 02

    May

  • 03

    May

  • 04

    May

  • 06

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 18

    May

  • 21

    May

  • 29

    May

  • 31

    May

  • 05

    Jun

ZM

Zoom Video

$64.49

1.175 (1.86%)

13:21
04/25/19
04/25
13:21
04/25/19
13:21
Hot Stocks
Zoom, Slack announce new partnership »

Zoom and Slack have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHC

Bausch Health

$23.18

0.16 (0.70%)

13:21
04/25/19
04/25
13:21
04/25/19
13:21
Hot Stocks
Bausch Health announces FDA approval of Duobrii for plaque psoriasis »

Bausch Health and its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 06

    May

  • 06

    May

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
04/25/19
04/25
13:17
04/25/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
04/25/19
04/25
13:16
04/25/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$382.62

7.3 (1.95%)

13:16
04/25/19
04/25
13:16
04/25/19
13:16
Recommendations
Boeing analyst commentary at Bernstein »

Bernstein says Aviation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 29

    May

  • 05

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.